| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/23/2011 | EP2285805A1 Aryl-quinolyl compounds and their use |
| 02/23/2011 | EP2285778A1 Nicotinamide derivatives |
| 02/23/2011 | EP2285774A1 Novel modulators of protein kinase signaling |
| 02/23/2011 | EP2285420A2 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer |
| 02/23/2011 | EP2285416A2 Conjugates for the treatment of mesothelioma |
| 02/23/2011 | EP2285406A2 Inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cells |
| 02/23/2011 | EP2285405A2 Vaccine compositions and methods |
| 02/23/2011 | EP2285402A2 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 02/23/2011 | EP2285394A2 Estrogenic extracts of anemarrhena asphodeloides bge from the liliaceae family and uses thereof |
| 02/23/2011 | EP2285392A2 Anticancer methods employing extracts of gleditsia sinensis lam |
| 02/23/2011 | EP2285385A2 siRNA COMPOUNDS FOR INHIBITING NRF2 |
| 02/23/2011 | EP2285369A2 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases |
| 02/23/2011 | EP2285350A2 Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles |
| 02/23/2011 | EP2285218A2 Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging |
| 02/23/2011 | EP2029184B1 Injectable fibrin composition for bone augmentation |
| 02/23/2011 | EP2010181B1 Methods of treating cell proliferative disorders by using pyrimidinediamine compounds |
| 02/23/2011 | EP1928492B1 Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy |
| 02/23/2011 | EP1919910B1 Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
| 02/23/2011 | EP1919905B1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-recptor tyrosine kinases |
| 02/23/2011 | EP1737451B1 Monocyclic heterocycles as kinase inhibitors |
| 02/23/2011 | EP1617218B1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR |
| 02/23/2011 | EP1524998B1 Stable aqueous pharmaceutical composition comprising erythropoietin |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1268096B2 Extrusion die |
| 02/23/2011 | EP1227805B2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/23/2011 | EP1135504B1 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 02/23/2011 | EP0972024B1 A tumor suppressor designated ts10q23.3 |
| 02/23/2011 | CN1946725B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 02/23/2011 | CN1902312B Method of constructing transgenic dendritic cell |
| 02/23/2011 | CN101981187A Partial peptide of Survivin presented on MHC class II molecule and use thereof |
| 02/23/2011 | CN101981060A Low-molecular-weight substance derived from maitake mushroom and having immunostimulating activity and anti-tumor activity |
| 02/23/2011 | CN101981056A Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof |
| 02/23/2011 | CN101981055A Anti-CD79B antibodies and immunoconjugates and methods of use |
| 02/23/2011 | CN101981054A Novel antibodies inhibiting c-MET dimerization, and uses thereof |
| 02/23/2011 | CN101981037A Pyrazolopyrimidine PI3K inhibitor compounds and methods of use |
| 02/23/2011 | CN101981033A Substituted imidazopyridazines useful as kinase inhibitors |
| 02/23/2011 | CN101981029A Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101981014A Crystalline salt forms of antifolate compounds and methods of manufacturing thereof |
| 02/23/2011 | CN101981013A Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors |
| 02/23/2011 | CN101980713A Anti-tumor agent comprising cytidine derivative and carboplatin |
| 02/23/2011 | CN101980712A Targeting microRNAs for the treatment of liver cancer |
| 02/23/2011 | CN101980707A Novel substituted imidazoquinolines |
| 02/23/2011 | CN101980699A Liquid and freeze dried formulations |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/23/2011 | CN101979594A Influenza virus hemagglutinin fusion peptide-containing targeted recombinant molecule gene, protein encoded thereby and application thereof |
| 02/23/2011 | CN101979566A Sulpho-oligodeoxynucleotide with immunostimulation activities and application thereof |
| 02/23/2011 | CN101979552A Structure of targeted hepatitis C virus (HCV)F gene and application of targeted HCVF gene |
| 02/23/2011 | CN101979549A Gene medicament taking voltage-gated proton channel Hv1 as targeted locus for treatment of breast cancer |
| 02/23/2011 | CN101979493A Anti-tumor kiwi liquor and preparation method thereof |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979382A Aminoindazole derivatives and use thereof as kinase inhibitors |
| 02/23/2011 | CN101979094A Method for preparing controlled degradable traditional Chinese medicine collagen and traditional Chinese medicine collagen prepared by same |
| 02/23/2011 | CN101979093A Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use |
| 02/23/2011 | CN101979090A Medicament for treating tumors |
| 02/23/2011 | CN101979076A Compound combination medicament for treating cerebral metastatic tumor and preparation method and application thereof |
| 02/23/2011 | CN101979052A Method for establishing high-performance liquid chromatography (HPLC) fingerprint of Guangxi dendrobium candidum wall. ex lindl and standard fingerprint of Guangxi dendrobium candidum wall. ex lindl |
| 02/23/2011 | CN101979030A Chinese medicinal ointment formula and preparation method and application thereof |
| 02/23/2011 | CN101979019A Traditional Chinese medicament for treating tumors |
| 02/23/2011 | CN101979018A Chinese medicament for treating tumors by using spreading hedyotis herb and preparation method |
| 02/23/2011 | CN101979017A Camellia chrysantha-mixed traditional Chinese medicine for treating tumor and preparation method thereof |
| 02/23/2011 | CN101979016A Traditional Chinese medicine for treating tumors by matching golden camellia |
| 02/23/2011 | CN101979013A Traditional Chinese medicine for treating leukemia |
| 02/23/2011 | CN101979003A Antitumor traditional Chinese medicine |
| 02/23/2011 | CN101978992A Black pepper extract with anti-tumor effect and medicinal preparation thereof |
| 02/23/2011 | CN101978990A Schisandra extract and preparation method and application thereof |
| 02/23/2011 | CN101978986A Chinese medicinal preparation for treating tumor and preparation method |
| 02/23/2011 | CN101978977A Self-emulsifying brucea javanica oil oral preparation composition and preparation method thereof |
| 02/23/2011 | CN101978975A Haematococcus extract preparation, and preparation method and use thereof |
| 02/23/2011 | CN101978963A Annonaceous acetogenin extract, preparation method thereof and use thereof in cancer resistance and relief of cancerous pain |
| 02/23/2011 | CN101978962A Medicinal composition for colon cancer and method for preparing effective monomers thereof |
| 02/23/2011 | CN101978960A Application of naphthalimide derivative as immunosuppressant |
| 02/23/2011 | CN101978959A Application of sphaelactone and derivative thereof to treatment of cancers |
| 02/23/2011 | CN101978952A Method for preparing berberine hydrochloride liposome preparation |
| 02/23/2011 | CN101978951A 9,10-diphenylanthracene(DPA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 02/23/2011 | CN101978950A Alpha-linolenic acid ester fat emulsion injection and preparation method thereof |
| 02/22/2011 | US7893279 Cyclohexanecarboxylic acid compound |
| 02/22/2011 | US7893259 Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof |
| 02/22/2011 | US7893246 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 02/22/2011 | US7893242 Oligonucleotide compositions and their use to induce apoptosis |
| 02/22/2011 | US7893223 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 02/22/2011 | US7893217 Isolated human antibodies that bind epitopes on RG1 |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893085 3-(4-Bromo-2-fluoro-phenylamino)-thieno[3,2-c]pyridine-2-carboxylic acid (2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-amide; mitogen activated protein extracellular kinase kinase (MEK) inhibitor; antiproliferative, antiinflammatory agent |
| 02/22/2011 | US7893078 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 02/22/2011 | US7893075 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 02/22/2011 | US7893072 Trp-p8 active compounds and therapeutic treatment methods |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893068 Physiologically active substances |
| 02/22/2011 | US7893065 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 02/22/2011 | US7893057 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | US7892833 Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions |
| 02/22/2011 | US7892828 Method of identifying a MHC class I restricted T cell response |
| 02/22/2011 | US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system |
| 02/22/2011 | US7892578 Treatment of hematologic disorders |
| 02/22/2011 | US7892559 Major histocompatibility complex class I restricted epitope peptide for use in diagnosis, prevention and treament of cell proliferative disorders; antitumor agents |
| 02/22/2011 | US7892556 Apoptotically active peptides |
| 02/22/2011 | US7892554 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |